Innoviva, Inc. (INVA)
22.06
-0.09
(-0.41%)
USD |
NASDAQ |
Mar 17, 16:00
22.06
0.00 (0.00%)
After-Hours: 16:38
Innoviva Market Cap : 1.634B for March 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 286.50B |
| Nektar Therapeutics | 1.300B |
| Regeneron Pharmaceuticals, Inc. | 80.23B |
| Oramed Pharmaceuticals, Inc. | 143.29M |
| Theravance Biopharma, Inc. | 704.85M |
Market Cap Related Metrics
| PE Ratio | 7.220 |
| PS Ratio | 4.117 |
| PEG Ratio | 0.0053 |
| Price to Book Value | 1.393 |
| Price to Free Cash Flow | 8.940 |
| Price | 22.06 |
| Earnings Yield | 13.85% |
| PEGY Ratio | 0.0053 |
| Operating PE Ratio | 10.69 |
| Normalized PE Ratio | 11.27 |